Načítá se...
In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin
BACKGROUND: Oxacillin continues to be an important agent in the treatment of staphylococcal infections; many generic products are available and the only requirement for their approval is demonstration of pharmaceutical equivalence. We tested the assumption that pharmaceutical equivalence predicts th...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2897798/ https://ncbi.nlm.nih.gov/pubmed/20525378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-10-153 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|